Understand the source comparison
SS-31 Men Over 40: Comparison of Mitochondrial Research Peptides
Men over 40 exploring mitochondrial support have several research peptides to compare. The table below contrasts SS-31 (elamipretide) with other commonly studied mitochondrial and metabolic compounds. SS-31 (Elamipretide) Cardiolipin stabilization, prevents cr
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Men over 40 exploring mitochondrial support have several research peptides to compare. The table below contrasts SS-31 (elamipretide) with other commonly studied mitochondrial and metabolic compounds.
- SS-31 (Elamipretide)
- Cardiolipin stabilization, prevents cristae disruption, reduces ROS at the source
- Heart failure, ischemia-reperfusion, mitochondrial myopathies, age-related decline
- 0.5–1.0 mg/kg SC daily
- Directly targets inner mitochondrial membrane; highest specificity
- Gold standard for mitochondrial membrane stabilization. Addresses upstream cause of ATP decline
- MOTS-c
- Mitochondrial-derived peptide; enhances insulin sensitivity, promotes mitochondrial biogenesis signaling
- Metabolic syndrome, insulin resistance, age-related metabolic decline
- 5–15 mg SC 2–3×/week
- Indirect. Signals nuclear gene expression for mitochondrial proteins
- Excellent for metabolic flexibility; less direct membrane protection than SS-31
- Humanin
- Mitochondrial-derived peptide; anti-apoptotic, neuroprotective, improves glucose metabolism
- Neurodegenerative disease, Alzheimer's models, metabolic dysfunction
- 2–4 mg SC daily
- Indirect. Modulates cellular stress response pathways
- Strong for neuroprotection; mitochondrial benefit is secondary to apoptosis inhibition
- NAD+ (subcutaneous)
- Cofactor for sirtuins and PARPs; supports mitochondrial protein acetylation and DNA repair
- General aging, NAD+ decline, mitochondrial dysfunction
- 50–100 mg SC 2–3×/week
- Supports mitochondrial enzymes but does not address membrane integrity
- Effective for NAD-dependent pathways; does not prevent cardiolipin oxidation
- Coenzyme Q10 (oral)
- Electron carrier in ETC; antioxidant at membrane level
- Statin-induced myopathy, general supplementation
- 100–300 mg oral daily
- Functions within ETC but does not stabilize cristae structure
- Limited bioavailability; benefits plateau at moderate doses; less targeted than SS-31
- SS-31 men over 40 comparing these options should note that SS-31's mechanism is the most structurally specific. While Mots C Peptide and NAD+ support mitochondrial function indirectly through gene expression and enzyme cofactor availability, only SS-31 directly prevents the oxidative damage to cardiolipin that initiates mitochondrial decline. For men prioritizing exercise capacity, cardiovascular resilience, and sustained ATP output under metabolic stress, SS-31 offers a mechanism no other peptide replicates.